Lv1
50 积分 2023-08-31 加入
FMO2 ameliorates nonalcoholic fatty liver disease by suppressing ER-to-Golgi transport of SREBP1
2个月前
已完结
EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis
2个月前
已完结
Ceramide-induced FGF13 impairs systemic metabolic health
2个月前
已完结
AP2M1 as the potential biomarker for prediction of the response of atopic dermatitis to Dupilumab therapy: Multi-omics analysis and evidence
2个月前
已完结
Behind the graduate mental health crisis in science
4个月前
已完结
Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
8个月前
已完结
Natural history and progression of metabolic dysfunction-associated steatotic liver disease
8个月前
已完结
A microbial metabolite inhibits the HIF-2α-ceramide pathway to mediate the beneficial effects of time-restricted feeding on MASH
8个月前
已完结
Interaction between the gut microbiota and colonic enteroendocrine cells regulates host metabolism
8个月前
已完结
Collaborative Governance in Theory and Practice
8个月前
已完结
皖公网安备34019202002308
